FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028259409> ?p ?o ?g. }

• W3028259409 abstract "Abstract Background Carvacrol is a food additive with various bioactivities, including reducing the blood glucose level as well as improvement of heart function, in diabetic mice. We explored the antihyperglycemic effect of carvacrol and its effect on the key hepatic enzymes accounting for glucose metabolism. Methods A streptozotocin (STZ)-induced diabetes-mellitus model in mice was used. Mice were divided randomly into a control group, diabetic group, low dose carvacrol-treated diabetic group (10 mg/kg body weight [BW]), and high dose carvacrol-treated diabetic group (20 mg/kg BW). Carvacrol was injected intraperitoneally (i.p.) in each carvacrol-treated group daily for 4 weeks and 6 weeks, respectively. The level of random plasma glucose, fasting plasma glucose, and plasma insulin was determined at 4 weeks and 6 weeks after carvacrol administration. The plasma level of total cholesterol (TC), triglycerides (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and the activity of hepatic key enzymes related to glucose metabolism were determined. Results Carvacrol treatment decreased the levels of random plasma glucose and fasting plasma glucose, significantly in a dose-dependent manner. A significant improvement in glucose tolerance and a significant decrease in the plasma level of TG were observed in carvacrol-treated diabetic mice at a dose of 20 mg/kg BW compared with that in vehicle-treated diabetic mice. There was no significant difference in the plasma level of TC and insulin between vehicle-treated diabetic mice and carvacrol-treated diabetic mice. Carvacrol treatment at a dose of 20 mg/kg BW significantly reduced the plasma level of LDH but not AST, ALT, or ALP, compared with that in the vehicle-treated diabetic group. The activity of hexokinase (HK), 6-phosphofructokinase (PFK), and citrate synthetase (CS) was increased by carvacrol treatment in diabetic mice. Conclusions Carvacrol exerted an anti-hyperglycemic effect in STZ-induced diabetic mice. This was achieved through regulating glucose metabolism by increasing the activity of the hepatic enzymes HK, PFK, and CS." @default.
• W3028259409 created "2020-05-29" @default.
• W3028259409 creator A5026470337 @default.
• W3028259409 creator A5041762347 @default.
• W3028259409 creator A5046634900 @default.
• W3028259409 creator A5046732565 @default.
• W3028259409 creator A5062492017 @default.
• W3028259409 creator A5083234708 @default.
• W3028259409 creator A5085339160 @default.
• W3028259409 date "2020-05-11" @default.
• W3028259409 modified "2023-10-16" @default.
• W3028259409 title "Effect of long-term treatment of Carvacrol on glucose metabolism in Streptozotocin-induced diabetic mice" @default.
• W3028259409 cites W1503760388 @default.
• W3028259409 cites W1603809034 @default.
• W3028259409 cites W1653800962 @default.
• W3028259409 cites W1719691205 @default.
• W3028259409 cites W185086710 @default.
• W3028259409 cites W1974088421 @default.
• W3028259409 cites W1976536739 @default.
• W3028259409 cites W1976840082 @default.
• W3028259409 cites W2003738118 @default.
• W3028259409 cites W2014887370 @default.
• W3028259409 cites W2015560493 @default.
• W3028259409 cites W2016924869 @default.
• W3028259409 cites W2019821959 @default.
• W3028259409 cites W2021871968 @default.
• W3028259409 cites W2035363830 @default.
• W3028259409 cites W2045454662 @default.
• W3028259409 cites W2074871320 @default.
• W3028259409 cites W2095335132 @default.
• W3028259409 cites W2116613046 @default.
• W3028259409 cites W2121876093 @default.
• W3028259409 cites W2122857852 @default.
• W3028259409 cites W2158982524 @default.
• W3028259409 cites W2163480595 @default.
• W3028259409 cites W2169478020 @default.
• W3028259409 cites W2227046901 @default.
• W3028259409 cites W2310840488 @default.
• W3028259409 cites W2528211973 @default.
• W3028259409 cites W2786527888 @default.
• W3028259409 cites W2883844768 @default.
• W3028259409 cites W2886396477 @default.
• W3028259409 cites W2948331265 @default.
• W3028259409 cites W2952337042 @default.
• W3028259409 cites W2959746018 @default.
• W3028259409 cites W2960093978 @default.
• W3028259409 cites W2964240783 @default.
• W3028259409 cites W2965722568 @default.
• W3028259409 cites W2966171751 @default.
• W3028259409 cites W2991885068 @default.
• W3028259409 cites W2997933217 @default.
• W3028259409 cites W2998508752 @default.
• W3028259409 cites W3000263092 @default.
• W3028259409 cites W3004913696 @default.
• W3028259409 cites W3010964964 @default.
• W3028259409 doi "https://doi.org/10.1186/s12906-020-02937-0" @default.
• W3028259409 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7216511" @default.
• W3028259409 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32393384" @default.
• W3028259409 hasPublicationYear "2020" @default.
• W3028259409 type Work @default.
• W3028259409 sameAs 3028259409 @default.
• W3028259409 citedByCount "11" @default.
• W3028259409 countsByYear W30282594092021 @default.
• W3028259409 countsByYear W30282594092022 @default.
• W3028259409 countsByYear W30282594092023 @default.
• W3028259409 crossrefType "journal-article" @default.
• W3028259409 hasAuthorship W3028259409A5026470337 @default.
• W3028259409 hasAuthorship W3028259409A5041762347 @default.
• W3028259409 hasAuthorship W3028259409A5046634900 @default.
• W3028259409 hasAuthorship W3028259409A5046732565 @default.
• W3028259409 hasAuthorship W3028259409A5062492017 @default.
• W3028259409 hasAuthorship W3028259409A5083234708 @default.
• W3028259409 hasAuthorship W3028259409A5085339160 @default.
• W3028259409 hasBestOaLocation W30282594091 @default.
• W3028259409 hasConcept C126322002 @default.
• W3028259409 hasConcept C134018914 @default.
• W3028259409 hasConcept C160160445 @default.
• W3028259409 hasConcept C17093226 @default.
• W3028259409 hasConcept C181199279 @default.
• W3028259409 hasConcept C185592680 @default.
• W3028259409 hasConcept C2777278459 @default.
• W3028259409 hasConcept C2777318727 @default.
• W3028259409 hasConcept C2779280383 @default.
• W3028259409 hasConcept C2779306644 @default.
• W3028259409 hasConcept C2780485761 @default.
• W3028259409 hasConcept C2780676017 @default.
• W3028259409 hasConcept C31903555 @default.
• W3028259409 hasConcept C55493867 @default.
• W3028259409 hasConcept C555293320 @default.
• W3028259409 hasConcept C71924100 @default.
• W3028259409 hasConceptScore W3028259409C126322002 @default.
• W3028259409 hasConceptScore W3028259409C134018914 @default.
• W3028259409 hasConceptScore W3028259409C160160445 @default.
• W3028259409 hasConceptScore W3028259409C17093226 @default.
• W3028259409 hasConceptScore W3028259409C181199279 @default.
• W3028259409 hasConceptScore W3028259409C185592680 @default.
• W3028259409 hasConceptScore W3028259409C2777278459 @default.
• W3028259409 hasConceptScore W3028259409C2777318727 @default.
• W3028259409 hasConceptScore W3028259409C2779280383 @default.
• W3028259409 hasConceptScore W3028259409C2779306644 @default.

• next